3SBio (HKSE:01530) Change In Inventory : HK$-41 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is 3SBio Change In Inventory?

3SBio's change in inventory for the quarter that ended in Dec. 2023 was HK$-7 Mil. It means 3SBio's inventory increased by HK$7 Mil from Jun. 2023 to Dec. 2023 .

3SBio's change in inventory for the fiscal year that ended in Dec. 2023 was HK$-41 Mil. It means 3SBio's inventory increased by HK$41 Mil from Dec. 2022 to Dec. 2023 .

3SBio's Total Inventories for the quarter that ended in Dec. 2023 was HK$850 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. 3SBio's Days Inventory for the quarter that ended in Dec. 2023 was 233.91.

Inventory Turnover measures how fast the company turns over its inventory within a year. 3SBio's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.78.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. 3SBio's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.19.

3SBio Change In Inventory Historical Data

The historical data trend for 3SBio's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio Change In Inventory Chart

3SBio Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-138.93

-110.38

-82.22

-54.39

-40.75

3SBio Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Inventory	Get a 7-Day Free Trial															-12.32	-114.32	54.51	-33.92	-6.84

3SBio Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-41 Mil.

3SBio (HKSE:01530) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

3SBio's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	829.94	/	647.538	*	365 / 2
	=	233.91

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

3SBio's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	647.538	/	829.94
	=	0.78

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

3SBio's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	829.94	/	4410.231
	=	0.19

3SBio Change In Inventory Related Terms

Thank you for viewing the detailed overview of 3SBio's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

3SBio (HKSE:01530) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio Inc (HKSE:01530) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

83B:Germany

Address

No. 3 A1, Road 10, Shenyang Economy and Technology Development Zone, Shenyang, CHN, 110027

Website

https://www.3sbio.com

3SBio Inc, or 3SBio, is one of the largest and most established biotech drugmakers in China. In 2021, it reported revenue of CNY 6.3 billion. Approximately 90% of its revenue is derived from four core drugs: TPIAO (rhTPO), Yisaipu (biosimilar of etanercept, a TNF-alpha inhibitor), rhEPO, and Mandi (minoxidil). With the exception of minoxidil, an over-the-counter drug, the others are all older generation biologics. Most of the pipeline candidates are "me-too" drugs and in general are still at an early stage.

Executives

Blackrock, Inc.	2201 Interest of corporation controlled by you
Lou Jing	2305 Beneficiary of a trust
Jpmorgan Chase & Co.	2502 Approved lending agent
Hsbc Holdings Plc	2302 Custodian
Citic Securities Company Limited	2201 Interest of corporation controlled by you
Citron Pe Associates, L.p.	2201 Interest of corporation controlled by you
Citron Pe Funds Limited	2201 Interest of corporation controlled by you
Citron Pe Holdings Limited	2201 Interest of corporation controlled by you
Cpechina Fund, L.p.	2201 Interest of corporation controlled by you
Cs Sunshine Investment Limited	2101 Beneficial owner
Tmf (cayman) Ltd.	2301 Trustee
Xing Lily
Century Sunshine Limited
Decade Sunshine Limited
Lambda International Limited

3SBio (HKSE:01530) Headlines

No Headlines